Works matching IS 10538569 AND DT 2014 AND VI 23 AND IP 4
Results: 18
Reply to the letter to the editor by Ramos-Quiroga et al.
- Published in:
- 2014
- By:
- Publication type:
- Other
Controlling controlled substances abuse and misuse by managed care payers: a new generation of risk management initiatives?
- Published in:
- 2014
- By:
- Publication type:
- Other
Risk of acute myocardial infarction, stroke, or death in patients initiating olmesartan or other angiotensin receptor blockers - a cohort study using the Clinical Practice Research Datalink.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2014, v. 23, n. 4, p. 340, doi. 10.1002/pds.3549
- By:
- Publication type:
- Article
Safety analysis of Ziagen® (abacavir sulfate) in postmarketing surveillance in Japan.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2014, v. 23, n. 4, p. 361, doi. 10.1002/pds.3589
- By:
- Publication type:
- Article
Differences among admitting departments in alerts and alert overrides for drug-drug interaction.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2014, v. 23, n. 4, p. 390, doi. 10.1002/pds.3591
- By:
- Publication type:
- Article
Safety analysis of Epzicom® (lamivudine/abacavir sulfate) in post-marketing surveillance in Japan.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2014, v. 23, n. 4, p. 372, doi. 10.1002/pds.3588
- By:
- Publication type:
- Article
Comments on: Are Food and Drug Administration prescription drug safety plans working? A case study of isotretinoin.
- Published in:
- 2014
- By:
- Publication type:
- Other
Guideline-recommended use of asthma medication by children is associated with parental information and knowledge: the PIAMA birth cohort.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2014, v. 23, n. 4, p. 406, doi. 10.1002/pds.3584
- By:
- Publication type:
- Article
Reply letter: are FDA prescription drug safety plans working? A case study of isotretinoin.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2014, v. 23, n. 4, p. 440, doi. 10.1002/pds.3577
- By:
- Publication type:
- Article
Cardiovascular and mortality risk in elderly Medicare beneficiaries treated with olmesartan versus other angiotensin receptor blockers.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2014, v. 23, n. 4, p. 331, doi. 10.1002/pds.3548
- By:
- Publication type:
- Article
The increase in prescriptions of bisphosphonates and the incidence proportion of osteonecrosis of the jaw after risk communication activities in Japan: a hospital-based cohort study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2014, v. 23, n. 4, p. 398, doi. 10.1002/pds.3562
- By:
- Publication type:
- Article
The challenges of comparing results between placebo controlled randomized trials and non-experimental new user, active comparator cohort studies: the example of olmesartan.
- Published in:
- 2014
- By:
- Publication type:
- Other
Response to Cunill et al.
- Published in:
- 2014
- By:
- Publication type:
- Other
The European Medicines Agency's use of prioritised independent research for best evidence in regulatory action on diclofenac.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2014, v. 23, n. 4, p. 431, doi. 10.1002/pds.3594
- By:
- Publication type:
- Article
Assessing the availability of the teratogenic drug isotretinoin outside the pregnancy prevention programme: a survey of e-pharmacies.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2014, v. 23, n. 4, p. 411, doi. 10.1002/pds.3565
- By:
- Publication type:
- Article
Effectiveness of interventions by community pharmacists to reduce risk of gastrointestinal side effects in nonselective nonsteroidal anti-inflammatory drug users.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2014, v. 23, n. 4, p. 382, doi. 10.1002/pds.3587
- By:
- Publication type:
- Article
Cardiac mortality in users of olmesartan, other angiotensin-receptor blockers and angiotensin-converting enzyme inhibitors.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2014, v. 23, n. 4, p. 348, doi. 10.1002/pds.3558
- By:
- Publication type:
- Article
Impact of a drug utilization review program on high-risk use of prescription controlled substances.
- Published in:
- 2014
- By:
- Publication type:
- Other